Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage
- Conditions
- Aneurysmal Subarachnoid Hemorrhage
- Interventions
- Procedure: Surgical clipping and endovascular coiling
- Registration Number
- NCT04785976
- Lead Sponsor
- Beijing Tiantan Hospital
- Brief Summary
Rupture of intracranial aneurysms can lead to extensive subarachnoid hemorrhage (SAH), a potentially fatal neurological emergency with mortality rates ranging from 8 to 67%. At present, surgical clipping (SC) and endovascular coiling (EC) are two main treatments for aneurysmal subarachnoid hemorrhage (aSAH), in recent years, the improvements in surgical equipment and techniques have already greatly improved the postoperative safety of patients. However, considering individual differences between patients, some still at risk due to possible complications during hospitalization or after discharge from the hospital, it will no doubt generate a large healthcare burden.
This prospective, observational clinical trial (LongTEAM) is to improve the diagnosis and treatment effect and efficiency in this field, reducing mortality, medical costs, and medical burden, while opening up new avenues for interdisciplinary clinical practice and scientific research exploration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
- All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry.
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Endovascular coiling Surgical clipping and endovascular coiling - Surgical clipping Surgical clipping and endovascular coiling -
- Primary Outcome Measures
Name Time Method Unfavorable neurological outcome (mRS>2) 24 months Number of patients experiencing a unfavorable neurological outcome at 24 months post-treatment, defined as a modified Rankin Scale (mRS) score of \>2.
- Secondary Outcome Measures
Name Time Method Cognitive deficits 24 months Number of patients experiencing a unfavorable neurological outcome at 24 months, defined as changes in thinking, emotion, will and behavior.
Major adverse cardiac or cerebrovascular events 24 months Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 24 months.
Trial Locations
- Locations (2)
Beijing Tiantan Hospital
🇨🇳Beijing, Beijing, China
The First People's Hospital of Neijiang
🇨🇳Neijiang, Sichuan, China